TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.
about
Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinomaAutoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.Association between murine double minute 2 T309G polymorphism and risk of liver cancer.The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients.MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjectsAssociation of p53 codon 72 polymorphism with susceptibility to hepatocellular carcinoma in a Chinese population from northeast Sichuan.Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis.MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.ASSOCIATION BETWEEN MURINE DOUBLE MINUTE 2 - T309G polymorphism and recurrence of hepatocellular carcinoma after surgical treatment.Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis.MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
P2860
Q26750792-EFA21459-45E9-4B81-A081-BEFEB3DA9B59Q33739952-940B1576-9543-4F89-B7A1-64CD05B6A7DFQ34380438-F4DEAE8A-D5AD-4ACA-966C-026A32AB857AQ34433411-38AAFB87-8BC4-46F6-9252-8400F758E62BQ35070151-FC23E171-2235-4E4F-AFBD-4FF65E854CCAQ35077721-5E7A3539-64C3-4853-B001-8340F2B1B0EBQ35612785-000C6618-0D55-46CC-AA58-A2BD7777EBA0Q35791375-14A84C83-66C9-47A3-B23C-35B13AABE609Q37700961-407B19DB-5867-470F-94C1-5CF4055853FEQ38425166-AA93F76D-C469-4E85-B0B5-7567F6CE3D61Q40382596-2A030101-436C-442A-A319-1235A17528E6Q40933867-4095DA21-94F3-4F86-B9EA-2645EC24795FQ40947646-B971696E-5056-484F-A1C4-AC14D5B74D1CQ46761401-3F2AA00B-3996-41C9-96F7-A5FAD63415C8Q52340395-406DEC99-2471-42DF-814F-5F57A2570834
P2860
TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
TP53 and MDM2 gene polymorphis ...... cinoma among Italian patients.
@ast
TP53 and MDM2 gene polymorphis ...... cinoma among Italian patients.
@en
type
label
TP53 and MDM2 gene polymorphis ...... cinoma among Italian patients.
@ast
TP53 and MDM2 gene polymorphis ...... cinoma among Italian patients.
@en
prefLabel
TP53 and MDM2 gene polymorphis ...... cinoma among Italian patients.
@ast
TP53 and MDM2 gene polymorphis ...... cinoma among Italian patients.
@en
P2093
P2860
P50
P356
P1476
TP53 and MDM2 gene polymorphis ...... cinoma among Italian patients.
@en
P2093
Franco M Buonaguro
Simona Losito
Valeria Di Vuolo
P2860
P2888
P356
10.1186/1750-9378-6-13
P577
2011-08-15T00:00:00Z
P5875
P6179
1044149282